Analysts Expect Amedisys Home Health and Hospice Care (AMED) Will Post Earnings of $0.77 Per Share

Equities analysts forecast that Amedisys Home Health and Hospice Care (NASDAQ:AMED) will report earnings of $0.78 per share for the current fiscal quarter, Zacks reports. Six analysts have issued estimates for Amedisys Home Health and Hospice Care’s earnings, with the lowest EPS estimate coming in at $0.76 and the highest estimate coming in at $0.80. Amedisys Home Health and Hospice Care posted earnings per share of $0.62 during the same quarter last year, which would suggest a positive year-over-year growth rate of 25.8%. The company is expected to issue its next earnings results on Wednesday, July 25th.

On average, analysts expect that Amedisys Home Health and Hospice Care will report full year earnings of $3.04 per share for the current fiscal year, with EPS estimates ranging from $2.99 to $3.07. For the next year, analysts anticipate that the business will report earnings of $3.37 per share, with EPS estimates ranging from $3.23 to $3.50. Zacks’ EPS averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Amedisys Home Health and Hospice Care.

Amedisys Home Health and Hospice Care (NASDAQ:AMED) last announced its quarterly earnings results on Monday, May 7th. The health services provider reported $0.79 earnings per share for the quarter, beating the consensus estimate of $0.67 by $0.12. The company had revenue of $399.30 million during the quarter, compared to analysts’ expectations of $395.38 million. Amedisys Home Health and Hospice Care had a return on equity of 16.83% and a net margin of 2.71%. Amedisys Home Health and Hospice Care’s quarterly revenue was up 9.5% on a year-over-year basis. During the same period last year, the business earned $0.47 earnings per share.

AMED has been the subject of several recent research reports. TheStreet upgraded Amedisys Home Health and Hospice Care from a “c+” rating to an “a-” rating in a research report on Monday, May 7th. Jefferies Group set a $70.00 price target on Amedisys Home Health and Hospice Care and gave the company a “buy” rating in a research report on Wednesday, February 28th. Zacks Investment Research upgraded Amedisys Home Health and Hospice Care from a “hold” rating to a “buy” rating and set a $57.00 price target for the company in a research report on Tuesday, February 6th. BidaskClub upgraded Amedisys Home Health and Hospice Care from a “hold” rating to a “buy” rating in a research report on Thursday, March 15th. Finally, ValuEngine upgraded Amedisys Home Health and Hospice Care from a “hold” rating to a “buy” rating in a research report on Tuesday, May 8th. Three investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. Amedisys Home Health and Hospice Care currently has an average rating of “Buy” and a consensus target price of $66.90.

Shares of Amedisys Home Health and Hospice Care opened at $73.21 on Wednesday, MarketBeat Ratings reports. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.63 and a quick ratio of 1.63. The company has a market cap of $2.52 billion, a P/E ratio of 33.13, a P/E/G ratio of 1.39 and a beta of 0.66. Amedisys Home Health and Hospice Care has a twelve month low of $45.60 and a twelve month high of $75.53.

In other news, insider Michael Paul North sold 11,000 shares of the business’s stock in a transaction that occurred on Friday, May 11th. The stock was sold at an average price of $71.52, for a total value of $786,720.00. Following the completion of the sale, the insider now directly owns 15,206 shares in the company, valued at $1,087,533.12. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.60% of the stock is owned by insiders.

Institutional investors have recently bought and sold shares of the company. Strs Ohio purchased a new stake in shares of Amedisys Home Health and Hospice Care in the fourth quarter valued at approximately $1,027,000. Arizona State Retirement System increased its position in shares of Amedisys Home Health and Hospice Care by 224.8% in the fourth quarter. Arizona State Retirement System now owns 47,913 shares of the health services provider’s stock valued at $2,525,000 after buying an additional 33,163 shares in the last quarter. Paloma Partners Management Co acquired a new stake in shares of Amedisys Home Health and Hospice Care in the fourth quarter worth approximately $310,000. Deutsche Bank AG boosted its stake in shares of Amedisys Home Health and Hospice Care by 174.8% in the fourth quarter. Deutsche Bank AG now owns 79,645 shares of the health services provider’s stock worth $4,196,000 after acquiring an additional 50,660 shares during the last quarter. Finally, Rhumbline Advisers boosted its stake in shares of Amedisys Home Health and Hospice Care by 16.2% in the fourth quarter. Rhumbline Advisers now owns 65,009 shares of the health services provider’s stock worth $3,427,000 after acquiring an additional 9,058 shares during the last quarter. Institutional investors and hedge funds own 94.07% of the company’s stock.

Amedisys Home Health and Hospice Care Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, and aides for its patients to complete their important personal tasks.

Get a free copy of the Zacks research report on Amedisys Home Health and Hospice Care (AMED)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Amedisys Home Health and Hospice Care (NASDAQ:AMED)

Receive News & Ratings for Amedisys Home Health and Hospice Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys Home Health and Hospice Care and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply